Idefirix 11 mg powder for concentrate for solution for infusion
20-HMedIdeS-19
Phase 3 small_molecule active
Quick answer
Idefirix 11 mg powder for concentrate for solution for infusion for End stage chronic kidney disease (CKD) patients who are highly sensitised and on the kidney transplant list awaiting a kidney transplant is a Phase 3 program (small_molecule) at Hansa Biopharma AB with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Hansa Biopharma AB
- Indication
- End stage chronic kidney disease (CKD) patients who are highly sensitised and on the kidney transplant list awaiting a kidney transplant
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active